Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.15M | -2.15M | -2.61M | -2.35M | -3.71M |
| Total Depreciation and Amortization | 1.27M | 1.00K | 289.10K | 1.00K | -1.00K |
| Total Amortization of Deferred Charges | -632.30K | 644.50K | 13.90K | 18.20K | 23.40K |
| Total Other Non-Cash Items | 46.00K | -41.20K | 790.70K | 168.80K | -208.10K |
| Change in Net Operating Assets | 1.90M | -869.10K | 548.20K | -467.30K | 537.10K |
| Cash from Operations | -567.60K | -2.42M | -973.00K | -2.63M | -3.36M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.40M | -- | -3.04M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.00K | -36.00K | -12.00K | -- | -- |
| Cash from Investing | -5.43M | -36.00K | -3.06M | -- | -- |
| Total Debt Issued | 5.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -65.30K | -63.40K |
| Issuance of Common Stock | -- | 3.50M | 2.26M | 200.00 | 3.78M |
| Repurchase of Common Stock | -274.40K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 275.00K | -290.80K | 4.30K | -31.20K | -54.10K |
| Cash from Financing | 5.00M | 3.21M | 2.27M | -96.40K | 3.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -999.70K | 755.90K | -1.76M | -2.72M | 305.10K |